Poet Technologies Stock Sold: Is It Time to Buy Now?
Poet Technologies stock sold off again as investors weigh dilution, growth prospects, and market jitters. This analys...
Take advantage of free courses on financial planning for beginners to boost your financial knowledge. Start your learning journey today.
15,301 articlesPoet Technologies stock sold off again as investors weigh dilution, growth prospects, and market jitters. This analys...
Citi initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Whirlpool reports softer first-quarter results, and its CEO cautions that spending trends resemble 2008-era weakness,...
The Michael biopic reclaimed the top spot with a domestic 26.1M, while Prada 2 trailed in second. New releases also j...
Standard Chartered Bank unveils a major automation plan with a 15% cut to back-office roles as it pivots to AI-driven...
As SpaceX eyes the public markets, investors buzz about a potential IPO rush and a comeback for stock-split enthusias...
When a biotech firm loses a meaningful backer, investors face a pivotal moment. This guide explains what it signals, ...
ARK’s latest AI IPO move put Cerebras at the center of a hype-filled market. Before you copy a big bet, learn the rea...
Quantum computing is edging toward mainstream impact, with a $72 billion forecast by 2035. This article uncovers thre...
As AI systems evolve, a watchdog warns 'rogue deployment' risk at top labs. This deep dive explains what rogue deploy...
AI-related debt now accounts for about 15% of the debt corporate bond market, signaling a shift that could alter risk...
A major fund’s exit from Ocular Therapeutix raises questions about timing, liquidity, and sector signals. This articl...